Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

There was a statistically significant increase in women with a claim for vitamin D between 2005 to 2011, with the largest increase among breast cancer patients aged ≥ 55 years (RR = 2.26; 95% CI, 2.11 to 2.42).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Trends in vitamin D supplement use in a general female and breast cancer population in Ireland: A repeated cross-sectional study

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Trends in vitamin D supplement use in a general female and breast cancer population in Ireland: A repeated cross-sectional study

Cross-sectional study · PLoS ONE · 2018

Original publication title

Trends in vitamin D supplement use in a general female and breast cancer population in Ireland: A repeated cross-sectional study

J. M. Madden; M. J. Duffy; L. Zgaga; K. Bennett

© 2018 Madden et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

This may have significant public health implications if associations between vitamin D and improved breast cancer survival prove to be causal.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Vitamin D has been linked with improved survival after breast cancer diagnosis but little is known about prescribing rates. This study investigates trends in vitamin D supplement use in both a general female and breast cancer population.

Source: Background

Abstract: What methods does the paper describe?

Women with a breast cancer diagnosis were identified from the National Cancer Registry of Ireland (n = 19870). Women who had any vitamin D claim between 2005 and 2011 were identified from pharmacy claims data (n = 8556). Prevalence rates were calculated as a proportion of all eligible women and by age (< 55 years, ≥ 55 years). Poisson regression was used to compare rates of vitamin D prescribing across years (risk ratio (RR), 95% CI).

Source: Methods

Abstract: Results

There was a statistically significant increase in women with a claim for vitamin D between 2005 to 2011, with the largest increase among breast cancer patients aged ≥ 55 years (RR = 2.26; 95% CI, 2.11 to 2.42).

Source: Results

Abstract: Conclusion

This may have significant public health implications if associations between vitamin D and improved breast cancer survival prove to be causal.

Source: Conclusion
Authors’ abstract

Background

Vitamin D has been linked with improved survival after breast cancer diagnosis but little is known about prescribing rates. This study investigates trends in vitamin D supplement use in both a general female and breast cancer population.

Methods

Women with a breast cancer diagnosis were identified from the National Cancer Registry of Ireland (n = 19870). Women who had any vitamin D claim between 2005 and 2011 were identified from pharmacy claims data (n = 8556). Prevalence rates were calculated as a proportion of all eligible women and by age (< 55 years, ≥ 55 years). Poisson regression was used to compare rates of vitamin D prescribing across years (risk ratio (RR), 95% CI).

Results

There was a statistically significant increase in women with a claim for vitamin D between 2005 to 2011, with the largest increase among breast cancer patients aged ≥ 55 years (RR = 2.26; 95% CI, 2.11 to 2.42).

Conclusion

This may have significant public health implications if associations between vitamin D and improved breast cancer survival prove to be causal.

Publication and source details

Original title: Trends in vitamin D supplement use in a general female and breast cancer population in Ireland: A repeated cross-sectional study

J. M. Madden; M. J. Duffy; L. Zgaga; K. Bennett

PLoS ONE · 2018

Competing Interests: The authors have declared that no competing interests exist.

* E-mail: jamiemadden@rcsi.ie
© 2018 Madden et al2018Madden et alhttps://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.This work was supported by the Irish Cancer Society Collaborative Cancer Research Centre BREAST-PREDICT (CCRC13GAL) and the Health Research Board Ireland (HRB-RL/2015/1579). The Health Research Board Ireland and the Irish Cancer Society had no role in the study design; collection, analysis, and interpretation of data; writing of the report; or the decision to submit for publication.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T20:42:12.153373+00:00

DOI: 10.1371/journal.pone.0209033 · PMC6292595